International pharmaceutical group, Ipsen presents its strategy based on focused innovation. Ipsen has two proprietary technologies that are world-class : peptides and toxins. Ipsen’s strategy is to focus on a limited number of diseases where the company can become a world-leader. Ipsen’s ambition is to continue to enrich its pipeline with the acquisition of new products
